Titan Medical Inc. Ordinary Shares
TMDI
TMDI was delisted on the 9th of March, 2023.
55 hedge funds and large institutions have $7.18M invested in Titan Medical Inc. Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 10 closing their positions.
18% more capital invested
Capital invested by funds: $6.11M → $7.18M (+$1.08M)
8% less funds holding
Funds holding: 60 → 55 (-5)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$812K |
| 2 |
RFA
Reilly Financial Advisors
La Mesa,
California
|
+$46.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$41.7K |
| 4 |
Jane Street
New York
|
+$18K |
| 5 |
LSA
Leonteq Securities AG
Zurich,
Switzerland
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$426K |
| 2 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$257K |
| 3 |
Millennium Management
New York
|
-$222K |
| 4 |
Two Sigma Advisers
New York
|
-$162K |
| 5 |
VF
Virtu Financial
New York
|
-$88K |
TMDI Hedge Fund Activity: Q3 2021 in Review
55 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Titan Medical Inc. Ordinary Shares (TMDI) for Q3 2021, worth a combined $7.18M — up 18% from $6.11M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TMDI and 7 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Masters Capital Management, adding an estimated $812K. The largest seller was Renaissance Technologies, cutting an estimated $426K.
- 55 institutional investors held Titan Medical Inc. Ordinary Shares (TMDI) as of Q3 2021, down from 60 in Q2 2021.
- Funds reported $7.18M of Titan Medical Inc. Ordinary Shares stock for Q3 2021, up 18% quarter-over-quarter.
- 7 funds opened new Titan Medical Inc. Ordinary Shares positions in Q3 2021 and 10 closed out, a net change of -3 holders.
- The largest Titan Medical Inc. Ordinary Shares buyer in Q3 2021 was Masters Capital Management, an estimated $812K added.
- The largest Titan Medical Inc. Ordinary Shares seller in Q3 2021 was Renaissance Technologies, an estimated $426K sold.
Based on aggregated 13F filings for Q3 2021.